REGN
Regeneron Pharmaceuticals Inc
$1078.73
1.30%
+13.82
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Loading
Key Stats
Market cap.
118.8B
Enterprise value
107B
Trailing PE
31.799236
Forward PE
22.368933
PEG Ratio
22.368933
Enterprise to EBITDA
24.182
Enterprise to revenue
8.167
Price to book MRQ
4.31195
Price to sales TTM
9.072445
Financials
Fiscal Year Ends
2023-12-31
Most Recent Quarter (MRQ)
2024-03-31
Revenue (TTM)
13.1B
EBITDA
5B
Diluted EPS TTM
33.92
Total Cash (MRQ)
10.5B
Current ratio (MRQ)
5.27
Operating Cash Flow (TTM)
4.7B
